Drugs / Piperacillin/Tazobactam
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02991937 Comparator | Dec 2016 → Dec 2020 | appendicitis | NYU Langone Health | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Piperacillin/Tazobactam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02991937 ↗ |
| Route | Intravenous | “24 hours of IV antibiotic administration” NCT02991937 ↗ |